The acid sphingomyelinase deficiency (ASMD) market is estimated to be valued at USD 151.2 Mn in 2025 and is expected to reach USD 340.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032 https://www.zupyak.com/p/4585624/t/acid-sphingomyelinase-deficiency-asmd-market-poised-for-growth-due-to-therapeutic-advances